healthy decline

The sp badly needs this re-rating. Investors are demanding a better risk/reward ratio for bearing risk, and a fair price for PGL shares is probably around the $1.50 mark. It has only just begun a Phase III trial, and too much blue sky has already been factored in causing astute investors to lock-in their profits as it has gotten ahead of itself.

I expect it to settle around $1.50 where a sensible investment case can probably me made. At the present time it is best to stay away while it corrects to fair levels.